First Time Loading...

DiaSorin SpA
MIL:DIA

Watchlist Manager
DiaSorin SpA Logo
DiaSorin SpA
MIL:DIA
Watchlist
Price: 101.35 EUR 2.85% Market Closed
Updated: May 14, 2024

Intrinsic Value

DiaSorin SpA engages in the development, production, and marketing of reagent kits for in vitro diagnostics. [ Read More ]

The intrinsic value of one DIA stock under the Base Case scenario is 88.1 EUR. Compared to the current market price of 101.35 EUR, DiaSorin SpA is Overvalued by 13%.

Key Points:
DIA Intrinsic Value
Base Case
88.1 EUR
Overvaluation 13%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
DiaSorin SpA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling DIA stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
DiaSorin SpA

Provide an overview of the primary business activities
of DiaSorin SpA.

What unique competitive advantages
does DiaSorin SpA hold over its rivals?

What risks and challenges
does DiaSorin SpA face in the near future?

Summarize the latest earnings call
of DiaSorin SpA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for DiaSorin SpA.

Provide P/S
for DiaSorin SpA.

Provide P/E
for DiaSorin SpA.

Provide P/OCF
for DiaSorin SpA.

Provide P/FCFE
for DiaSorin SpA.

Provide P/B
for DiaSorin SpA.

Provide EV/S
for DiaSorin SpA.

Provide EV/GP
for DiaSorin SpA.

Provide EV/EBITDA
for DiaSorin SpA.

Provide EV/EBIT
for DiaSorin SpA.

Provide EV/OCF
for DiaSorin SpA.

Provide EV/FCFF
for DiaSorin SpA.

Provide EV/IC
for DiaSorin SpA.

Show me price targets
for DiaSorin SpA made by professional analysts.

What are the Revenue projections
for DiaSorin SpA?

How accurate were the past Revenue estimates
for DiaSorin SpA?

What are the Net Income projections
for DiaSorin SpA?

How accurate were the past Net Income estimates
for DiaSorin SpA?

What are the EPS projections
for DiaSorin SpA?

How accurate were the past EPS estimates
for DiaSorin SpA?

What are the EBIT projections
for DiaSorin SpA?

How accurate were the past EBIT estimates
for DiaSorin SpA?

Compare the revenue forecasts
for DiaSorin SpA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of DiaSorin SpA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of DiaSorin SpA against its competitors.

Analyze the profit margins
(gross, operating, and net) of DiaSorin SpA compared to its peers.

Compare the P/E ratios
of DiaSorin SpA against its peers.

Discuss the investment returns and shareholder value creation
comparing DiaSorin SpA with its peers.

Analyze the financial leverage
of DiaSorin SpA compared to its main competitors.

Show all profitability ratios
for DiaSorin SpA.

Provide ROE
for DiaSorin SpA.

Provide ROA
for DiaSorin SpA.

Provide ROIC
for DiaSorin SpA.

Provide ROCE
for DiaSorin SpA.

Provide Gross Margin
for DiaSorin SpA.

Provide Operating Margin
for DiaSorin SpA.

Provide Net Margin
for DiaSorin SpA.

Provide FCF Margin
for DiaSorin SpA.

Show all solvency ratios
for DiaSorin SpA.

Provide D/E Ratio
for DiaSorin SpA.

Provide D/A Ratio
for DiaSorin SpA.

Provide Interest Coverage Ratio
for DiaSorin SpA.

Provide Altman Z-Score Ratio
for DiaSorin SpA.

Provide Quick Ratio
for DiaSorin SpA.

Provide Current Ratio
for DiaSorin SpA.

Provide Cash Ratio
for DiaSorin SpA.

What is the historical Revenue growth
over the last 5 years for DiaSorin SpA?

What is the historical Net Income growth
over the last 5 years for DiaSorin SpA?

What is the current Free Cash Flow
of DiaSorin SpA?

Discuss the annual earnings per share (EPS)
trend over the past five years for DiaSorin SpA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
DiaSorin SpA

Current Assets 982.7m
Cash & Short-Term Investments 403.4m
Receivables 228.7m
Other Current Assets 350.6m
Non-Current Assets 2.2B
Long-Term Investments 12.9m
PP&E 256.3m
Intangibles 1.9B
Other Non-Current Assets 34.6m
Current Liabilities 320.1m
Accounts Payable 100.7m
Accrued Liabilities 66.2m
Other Current Liabilities 153.2m
Non-Current Liabilities 1.4B
Long-Term Debt 1.1B
Other Non-Current Liabilities 269.7m
Efficiency

Earnings Waterfall
DiaSorin SpA

Revenue
1.1B EUR
Cost of Revenue
-407m EUR
Gross Profit
741.2m EUR
Operating Expenses
-503.3m EUR
Operating Income
237.8m EUR
Other Expenses
-78m EUR
Net Income
159.8m EUR

Free Cash Flow Analysis
DiaSorin SpA

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

DIA Profitability Score
Profitability Due Diligence

DiaSorin SpA's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive 3-Year Average ROE
59/100
Profitability
Score

DiaSorin SpA's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

DIA Solvency Score
Solvency Due Diligence

DiaSorin SpA's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
High Altman Z-Score
Long-Term Solvency
Low D/E
59/100
Solvency
Score

DiaSorin SpA's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DIA Price Targets Summary
DiaSorin SpA

Wall Street analysts forecast DIA stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DIA is 98.47 EUR with a low forecast of 75.75 EUR and a high forecast of 115.5 EUR.

Lowest
Price Target
75.75 EUR
25% Downside
Average
Price Target
98.47 EUR
3% Downside
Highest
Price Target
115.5 EUR
14% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

DIA Price
DiaSorin SpA

1M 1M
+16%
6M 6M
+11%
1Y 1Y
-2%
3Y 3Y
-25%
5Y 5Y
+13%
10Y 10Y
+294%
Annual Price Range
101.35
52w Low
82
52w High
104.4162
Price Metrics
Average Annual Return 12.25%
Standard Deviation of Annual Returns 29.7%
Max Drawdown -60%
Shares Statistics
Market Capitalization 5.4B EUR
Shares Outstanding 54 446 611
Percentage of Shares Shorted
N/A

DIA Return Decomposition
Main factors of price return

What is price return decomposition?

DIA News

Other Videos

Company Profile

DiaSorin SpA Logo
DiaSorin SpA

Country

Italy

Industry

Health Care

Market Cap

5.4B EUR

Dividend Yield

1.16%

Description

DiaSorin SpA engages in the development, production, and marketing of reagent kits for in vitro diagnostics. The company is headquartered in Saluggia, Vercelli and currently employs 3,358 full-time employees. The company went IPO on 2007-07-19. The firm specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The firm develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company’s business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. The company operates through ELISA immunodiagnostic business portfolio.

Contact

VERCELLI
Saluggia
Via Crescentino snc
+390161487526.0
http://www.diasorin.com/

IPO

2007-07-19

Employees

3 358

Officers

CEO, GM & Executive Director
Mr. Carlo Rosa
Chief Commercial Officer, Senior Corporate VP of Commercial Operations & Executive Director
Dr. Chen Menachem Even
Senior Corporate VP, CFO & Corporate Accounting Documents Officer
Mr. Piergiorgio Pedron
Corporate VP & Chief Technology Officer
Mr. Fabrizio Piercarlo Bonelli
Corporate Vice President of Communication & Investor Relations
Dr. Riccardo Fava
Corporate VP, Head of the Legal Department, Secretary & General Counsel
Mr. Ulisse Spada
Show More
Senior Corporate Vice President of Human Resources
Mr. Stefano Ronchi
President of Luminex Corporation
Mr. Angelo Rago
Show Less

See Also

Discover More
What is the Intrinsic Value of one DIA stock?

The intrinsic value of one DIA stock under the Base Case scenario is 88.1 EUR.

Is DIA stock undervalued or overvalued?

Compared to the current market price of 101.35 EUR, DiaSorin SpA is Overvalued by 13%.